XML 47 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Agreements - Roche (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jan. 31, 2019
May 31, 2000
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Collaborative Agreements disclosures            
Non-cash royalty revenue related to sale of future royalties         $ 45,159 $ 32,102
Revenue previously deferred     $ 72 $ 79 1,300 237
Milestone payments            
Collaborative Agreements disclosures            
Revenue previously deferred         39,000  
Roche            
Collaborative Agreements disclosures            
Period in arrears to receive royalty reports and payments related to sales of Kadcyla   3 months        
Percentage of royalty payments 100.00%          
Roche | License and milestone fees | Regulatory milestones            
Collaborative Agreements disclosures            
Revenue previously deferred           5,000
Roche | Kadcyla            
Collaborative Agreements disclosures            
Non-cash royalty revenue related to sale of future royalties         45,200 $ 32,100
OMERS | Kadcyla            
Collaborative Agreements disclosures            
Non-cash royalty revenue related to sale of future royalties $ 65,200          
Percentage of royalty payments 100.00%          
Maximum | Roche | Milestone payments            
Collaborative Agreements disclosures            
Potential milestone payments     $ 44,000   $ 44,000